Mental Depression
|
0.600 |
Biomarker
|
disease |
BEFREE |
Serum S100B can be used as a biomarker of depression.
|
30745657 |
2020 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Serum S100B can be used as a biomarker of depression.
|
30745657 |
2020 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
These data suggest that ethnicity or race should be given serious consideration when studying and interpreting S100b levels in persons with schizophrenia.
|
31786729 |
2020 |
melanoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Shave biopsy and immunohistochemical studies revealed that the tumor was composed of malignant melanoma (MM) (highlighted by S100 and MART-1) intermixed with squamous cell carcinoma (SCC) (highlighted by cytokeratin and p63), and a diagnosis of combined MM-SCC was rendered.
|
31361351 |
2020 |
melanoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
S100, human melanoma black 45, and melanoma antigen recognized by t-cell (Melan A) were negative.
|
30978337 |
2020 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Mts1 is a member of the S100 protein family and is involved in tumor progression and metastasis.
|
31467231 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
However, few S-100 positive lipoblasts suggested the origin of the tumor.
|
31796335 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Shave biopsy and immunohistochemical studies revealed that the tumor was composed of malignant melanoma (MM) (highlighted by S100 and MART-1) intermixed with squamous cell carcinoma (SCC) (highlighted by cytokeratin and p63), and a diagnosis of combined MM-SCC was rendered.
|
31361351 |
2020 |
Depressed mood
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Serum S100B can be used as a biomarker of depression.
|
30745657 |
2020 |
Delirium
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
After adjusting for age, gender, Acute Physiology and Chronic Health Evaluation II score, Charlson comorbidity score, sepsis diagnosis and study intervention group, interleukin-6, -8, and -10, tumor necrosis factor-α, C-reactive protein, and S-100β levels in quartile 4 were negatively associated with delirium-/coma-free days by 1 week and 30 days post enrollment.
|
31770149 |
2020 |
Delirium
|
0.080 |
Biomarker
|
disease |
BEFREE |
We measured the independent associations between intraoperative F2-isoprostanes and isofurans and delirium (primary outcome) and postoperative ubiquitin carboxyl-terminal hydrolase isozyme L1 (secondary outcome), and we assessed if S100 calcium-binding protein B modified these associations.
|
31770146 |
2020 |
Tumor Progression
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Mts1 is a member of the S100 protein family and is involved in tumor progression and metastasis.
|
31467231 |
2020 |
Neurodegenerative Disorders
|
0.080 |
AlteredExpression
|
group |
BEFREE |
Alterations of S100B level were noted in various neurodegenerative diseases.
|
31705442 |
2020 |
Lupus Erythematosus, Systemic
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Association of S100B polymorphisms and serum S100B with risk of systemic lupus erythematous in a Chinese population.
|
31271591 |
2020 |
Squamous cell carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Shave biopsy and immunohistochemical studies revealed that the tumor was composed of malignant melanoma (MM) (highlighted by S100 and MART-1) intermixed with squamous cell carcinoma (SCC) (highlighted by cytokeratin and p63), and a diagnosis of combined MM-SCC was rendered.
|
31361351 |
2020 |
Glaucoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
The inhibition of S100B release or microglia response could potentially decrease the damage in degenerative diseases, like glaucoma.
|
31705442 |
2020 |
Systemic onset juvenile chronic arthritis
|
0.030 |
Biomarker
|
disease |
BEFREE |
We aimed to examine IL-18 levels in sJIA in relation to disease activity and history of MAS and other disease biomarkers namely S100 proteins and CXCL9.
|
31326996 |
2020 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.020 |
Biomarker
|
disease |
BEFREE |
Also, serum levels of S100A4, S100A8/S100A9, S100A12, and S100B correlate with insulin resistance/type 2 diabetes, metabolic risk score, and fat cell size.
|
31363816 |
2020 |
Obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
Certain S100 proteins, namely S100A4, the S100A8/S100A9 heterodimer and S100B, have been implicated in the pathophysiology of obesity-promoting macrophage-based inflammation via toll-like receptor 4 and/or receptor for advanced glycation end-products ligation.
|
31363816 |
2020 |
Indeterminate dendritic cell tumor
|
0.020 |
Biomarker
|
disease |
BEFREE |
Diffuse dermal infiltration of a mixture of histiocytes and lymphocytes accompanied with multinuclear giant cells, the positive CD68 and Factor XIIIa and negative Langerin immunoreactions, along with the positive staining with CD1a and S100, led us to the diagnosis of ICH.
|
31789127 |
2020 |
Hyperglycemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The increased postoperative NSE and S100B levels in the IIFG group compared with controls may be associated with severe insulin resistance and stress hyperglycemia.
|
30430888 |
2020 |
Lupus Vulgaris
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of S100B polymorphisms and serum S100B with risk of systemic lupus erythematous in a Chinese population.
|
31271591 |
2020 |
Lupus Erythematosus, Discoid
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of S100B polymorphisms and serum S100B with risk of systemic lupus erythematous in a Chinese population.
|
31271591 |
2020 |
Polycystic Ovary Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
S100-A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF-κB pathway in polycystic ovary syndrome.
|
31568644 |
2020 |
Proliferative diabetic retinopathy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy.
|
31571092 |
2020 |